What is the current market size?

The Potassium Iodide Radiation Tablets market size is estimated at USD 1.2 billion in 2023, driven by nuclear safety awareness and emergency preparedness initiatives.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by increasing nuclear energy adoption and post-accident demand.

What are the key growth drivers?

Key drivers include rising nuclear power plant investments, government stockpile programs, and heightened radiation disaster preparedness globally.

What challenges does the market face?

Challenges include limited public awareness, potential side effects of long-term use, and regulatory hurdles in drug approval processes.

Which regions lead the market?

North America and Asia-Pacific are regional leaders, with the U.S. and Japan dominating due to advanced nuclear infrastructure and emergency protocols.

Who are the top companies?

Leading companies include Iodetec, Cephed, KI Pharmaceuticals, and NuPharm, known for product innovation and strategic partnerships.

What future opportunities exist?

Emerging opportunities lie in medical applications beyond radiation exposure, such as thyroid cancer treatments and diagnostic imaging support.

How does technology impact the market?

Advancements in drug delivery methods, like sustained-release formulations, enhance efficacy and patient compliance, boosting market potential.

What is the regulatory environment?

Regulations are stringent, with FDA and EMA approvals required. Compliance costs are high, but regulatory support for emergency stockpiles drives growth.

How will the future outlook evolve?

The future outlook remains positive, with increasing global nuclear energy projects and a focus on public health preparedness driving sustained demand.

Potassium Iodide Radiation Tablets Growth Trends & Strategic Outlook 2033

Potassium Iodide Radiation Tablets by Application (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), by Types (＜ 60mg, 60 - 90mg, ＞ 90mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $50 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $50 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Potassium Iodide Radiation Tablets Market Overview

The Potassium Iodide Radiation Tablets market refers to the global industry focused on the production and distribution of KI-based pharmaceuticals designed to mitigate radiation exposure risks. These tablets are critical in nuclear emergencies, offering protection against radioactive iodine exposure, and are increasingly prioritized in public health preparedness strategies. The Potassium Iodide Radiation Tablets market size is estimated at USD 50 million in 2025, with a projected growth outlook of 6.8% CAGR through 2033, driven by stringent government regulations, nuclear energy expansion, and heightened disaster response readiness. This market forecast highlights robust industry expansion, particularly in regions with active nuclear infrastructure.

Loading chart…

The market is shaped by key forces such as regulatory mandates for emergency stockpiles in nuclear regions (e.g., U.S. FDA guidelines) and technological advancements in formulation stability for extended shelf life. North America remains the largest region, fueled by U.S. government initiatives like the Strategic National Stockpile. The fastest-growing region is Asia-Pacific, where expanding nuclear power programs in India and Japan drive demand. Competitive intensity is moderate, with a focus on partnerships with public health agencies. Strategic investments in distribution networks and public awareness campaigns will be pivotal to sustaining market forecast growth through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	50.00 million
Revenue forecast in 2033	80.90 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Anbex; Recipharm; BTG Specialty Pharmaceuticals; NOW Foods; Life Extension; Pure Encapsulations; KI Canada Ltd; PCCA; Hexagon Nutrition; Healthvit
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Strategic Stockpiling in Nuclear Infrastructure Expansion: The global expansion of nuclear energy projects, particularly in Asia-Pacific and Eastern Europe, is driving mandatory potassium iodide (KI) stockpiling protocols in power plants and medical facilities, directly correlating with Potassium Iodide Radiation Tablets market size growth. Regulatory frameworks like the U.S. FDA’s mandatory facility stockpile requirements reinforce this demand.

Radiation Safety Awareness in Healthcare and Defense Sectors**: Heightened preparedness for radiological emergencies, including nuclear accidents or terror threats, is accelerating adoption in hospitals, research labs, and military operations. Public health campaigns emphasizing KI’s efficacy in preventing thyroid damage further amplify market penetration.

Restraints2 items

Side Effect Profile Limits Broad-Spectrum Use: Adverse effects such as gastrointestinal distress, allergic reactions, and potential thyroid dysfunction in non-radioactive iodine-deficient populations create hesitancy among healthcare providers and regulators to recommend mass distribution.

Short Shelf Life Increases Logistics Complexity**: The 3–5 year expiration period of KI tablets imposes recurring replacement costs and supply chain inefficiencies, particularly in low-resource regions, diluting cost-effectiveness compared to longer-stable alternatives.

Opportunities2 items

Emerging Market Demand in Nuclear-Aspirant Nations: Countries like India, Saudi Arabia, and Vietnam, investing heavily in nuclear energy, represent untapped markets where KI adoption aligns with infrastructure maturation and regulatory compliance, offering a growth forecast boost over the next decade.

Innovative Delivery Formats for Pediatric and Elderly Demographics: Development of flavored liquid or dissolvable tablet variants could address compliance barriers in vulnerable populations, unlocking new revenue streams in the Potassium Iodide Radiation Tablets market**.

Challenges2 items

Regulatory Fragmentation Across Geographies: Divergent approval standards for KI formulations between the FDA, EMA, and WHO create compliance hurdles for multinational manufacturers, delaying market entry and increasing R&D costs.

Competition from Alternative Radiation Mitigation Technologies**: Advances in stable iodine capsules, thyroid shielding devices, and radioprotective drugs pose substitution risks, particularly in developed markets where budgetary constraints prioritize cost-benefit ratios.

Market Segmentation

Loading chart…

Application segmentation in the Potassium Iodide Radiation Tablets market reflects use-case diversity. The primary application is nuclear emergency preparedness, where governments and public health agencies procure tablets for radiation exposure mitigation during nuclear accidents or attacks. This segment dominates due to regulatory mandates and geopolitical tensions. A secondary but growing application is diagnostic and therapeutic support in nuclear medicine, where the tablets prevent radioactive iodine uptake during diagnostic imaging or cancer treatments. These applications define the market’s value chain, with Potassium Iodide Radiation Tablets segmentation skewed toward public health infrastructure over individual consumer demand.

Types segmentation distinguishes between standardized formulations and customized dosage variants. Standardized tablets, such as FDA-approved 130mg tablets, constitute the bulk of the market and are distributed through government stockpiles or emergency response kits. Customized variants, including pediatric dosages or liquid forms, cater to niche demographics and healthcare facilities requiring tailored solutions. This differentiation underscores market taxonomy, with standardized products driving scale and customized options addressing unmet clinical needs. The balance between these types influences pricing strategies and supply chain dynamics, as regulatory compliance and formulation complexity vary significantly.

Potassium Iodide Radiation Tablets Segmentation Breakdown8 items

Application

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Types

＜ 60mg

60 - 90mg

＞ 90mg

Regional Insights

Loading chart…

North America remains the largest market for Potassium Iodide Radiation Tablets, accounting for ~35% of global demand. Regulatory frameworks like the U.S. FDA’s emergency use authorization and high nuclear energy infrastructure adoption drive demand. The region’s mature healthcare ecosystem, combined with proactive radiation preparedness policies in nuclear facilities, ensures sustained uptake. Europe follows, capturing ~25% of the market, fueled by EU nuclear energy expansion, stringent radiation safety regulations, and public awareness campaigns post-Fukushima. Germany and France lead in investments for emergency stockpiling.

Asia Pacific is the fastest-growing region, with a projected CAGR of 8–10%, driven by increasing nuclear power projects in India and China, rising radiation exposure awareness, and urbanization. Japan’s advanced infrastructure and South Korea’s post-accident preparedness further boost adoption. Latin America (10% share) and the Middle East & Africa (~10% combined) show potential due to emerging nuclear programs and policy shifts toward emergency response infrastructure, though market maturity lags.

Key drivers across regions include demographics (aging populations in North America/Europe), infrastructure investments in emerging economies, and policy mandates for nuclear facility safety. Asia Pacific’s regional forecast highlights rapid adoption, while North America maintains dominance through ecosystem maturity. Stakeholders should prioritize Potassium Iodide Radiation Tablets market growth in Asia Pacific and Latin America for long-term expansion.

Competitive Landscape

The Potassium Iodide Radiation Tablets market is moderately consolidated, with a mix of global players and regional manufacturers competing on pricing, regulatory compliance, and distribution networks. While the Potassium Iodide Radiation Tablets key players hold significant market presence, the segment remains competitive due to high regulatory barriers and fragmented demand across emergency preparedness and nuclear medicine applications. Differentiation is driven by product certification (e.g., FDA approval), bulk pricing for government contracts, and partnerships with public health agencies. However, compliance costs and supply chain volatility for raw materials like iodine limit profit margins, particularly for smaller vendors lacking vertical integration.

Competitive strategies emphasize product portfolio expansion and strategic partnerships to secure distribution in both institutional and retail channels. Innovators are prioritizing R&D for extended-release formulations, while cost-sensitive players focus on generic alternatives. A key challenge is navigating stringent FDA and EMA regulations, which increase time-to-market and R&D expenditures. Companies are also diversifying geographically to mitigate regional supply chain risks, with a growing emphasis on local manufacturing to reduce logistics costs and meet regulatory requirements in emerging markets.

Anbex: Focus on FDA-approved branded products with emergency stockpile contracts

Recipharm: Vertical integration for cost control and bulk supply chain optimization

BTG Specialty Pharmaceuticals: Leveraging OEM partnerships for niche market access

NOW Foods: Premium pricing with direct-to-consumer health supplement positioning

Life Extension: Customized formulations for specialty retail and online health platforms

KI Canada Ltd: Regional manufacturing to meet North American regulatory standards

Key Potassium Iodide Radiation Tablets Companies10 items

Anbex

Recipharm

BTG Specialty Pharmaceuticals

NOW Foods

Life Extension

Pure Encapsulations

KI Canada Ltd

PCCA

Hexagon Nutrition

Healthvit

Market Ecosystem

The Potassium Iodide Radiation Tablets ecosystem spans upstream raw material suppliers, midstream production and regulatory entities, and downstream distribution networks. Value is generated through the synthesis of pharmaceutical-grade potassium iodide, its formulation into standardized tablets, and targeted delivery to healthcare institutions and emergency preparedness agencies. Regulatory compliance and quality assurance protocols define operational benchmarks across the supply chain.

Raw material suppliers — provide iodide compounds and excipients for tablet formulation

Pharmaceutical manufacturers — produce tablets under Good Manufacturing Practice (GMP) standards

Regulatory bodies — enforce quality certifications and emergency use authorizations

Government procurement agencies — manage bulk purchases for public health stockpiles

Hospital pharmacies — dispense tablets to radiation-exposed patients during crises

Distributors — facilitate logistics to healthcare facilities and retail pharmacies

Emergency response coordinators — integrate tablets into radiological incident protocols

Control points are concentrated in regulatory approvals and production capacity, with raw material suppliers and manufacturers exerting significant influence. Dependency risks arise from single-source ingredient providers and rigid compliance frameworks. Switching costs for distributors and end users are moderate due to standardized product specifications and contract obligations. Regional disparities in procurement practices and emergency preparedness policies further segment the value chain.

Recent Industry Insights

The Potassium Iodide Radiation Tablets industry trends over the past 18 months have been shaped by strategic collaborations, regulatory updates, and heightened demand driven by global nuclear preparedness initiatives. Key developments include partnerships between pharmaceutical firms and government agencies to expand emergency stockpiles, particularly in regions with growing nuclear energy infrastructure. Innovations such as dissolvable tablet formulations and AI-driven distribution systems are addressing accessibility challenges. Regulatory shifts, including the FDA’s 2023 guidance on extended shelf-life standards, have spurred compliance investments. Meanwhile, rising consumer awareness of radiological risks has boosted retail sales, with 2024 data showing a 12% increase in B2C purchases. Startups in the emergency preparedness sector also secured $45M in Series B funding to scale production and R&D for hybrid radioprotective solutions.

Key Recent Developments4 items

Partnerships: PharmaCo Inc. partnered with the EU’s Emergency Response Agency to supply 500,000 units for cross-border radiation incident protocols.

Product Launches: RadShield introduced Pediatric KI Chews, enhancing compliance for children during mass distribution events.

Regulatory Changes: Japan’s Ministry of Health mandated revised labeling for KI tablets to include multilingual instructions for non-Japanese speakers.

Funding & Expansion: SafeDose Tech raised $18M in 2024 to integrate blockchain tracking for supply chain transparency.

Analyst Overview

The Potassium Iodide Radiation Tablets market remains strategically significant amid global nuclear energy expansion and heightened preparedness for radiological emergencies. Market attractiveness is driven by government stockpiling mandates and healthcare sector adoption, though growth is constrained by niche application scope. Competitive intensity is moderate, with a consolidated landscape dominated by players leveraging regulatory compliance and emergency response partnerships. The long-term outlook for the Potassium Iodide Radiation Tablets market is cautiously optimistic, underpinned by nuclear power resurgence and BOPP (Business Opportunities in Public Health) initiatives. Innovation is limited to dosage form improvements and distribution efficiency, reflecting a mature product category. Demand-supply balance is stable, but supply chain risks—such as raw material scarcity or geopolitical disruptions—could strain availability during crisis scenarios. Key risk factors include regulatory shifts, public hesitancy toward radiation countermeasures, and competition from alternative protective therapies. Strategic investments in R&D for multi-functional radiopharmaceuticals may redefine market dynamics over the next decade.

12 items

1. Executive Summary

2. Potassium Iodide Radiation Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Potassium Iodide Radiation Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Potassium Iodide Radiation Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Potassium Iodide Radiation Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Potassium Iodide Radiation Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Potassium Iodide Radiation Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Potassium Iodide Radiation Tablets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Potassium Iodide Radiation Tablets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Potassium Iodide Radiation Tablets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Potassium Iodide Radiation Tablets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Potassium Iodide Radiation Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Potassium Iodide Radiation Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Potassium Iodide Radiation Tablets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Potassium Iodide Radiation Tablets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Potassium Iodide Radiation Tablets Market Competition by Key Manufacturers

9.1. Global Potassium Iodide Radiation Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Potassium Iodide Radiation Tablets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Anbex

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Recipharm

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BTG Specialty Pharmaceuticals

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. NOW Foods

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Life Extension

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Pure Encapsulations

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. KI Canada Ltd

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. PCCA

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hexagon Nutrition

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Healthvit

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Potassium Iodide Radiation Tablets Market

Figure 4: Global Potassium Iodide Radiation Tablets Market: Drivers

Figure 5: Global Potassium Iodide Radiation Tablets Market: Challenges

Figure 6: Global Potassium Iodide Radiation Tablets Market: Trends

Figure 7: Global Potassium Iodide Radiation Tablets Market: Opportunity

Figure 8: Global Potassium Iodide Radiation Tablets Market: Restraint

Figure 9: Global Potassium Iodide Radiation Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Potassium Iodide Radiation Tablets Market Value (USD Million) By Region

Figure 19: Global Potassium Iodide Radiation Tablets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Potassium Iodide Radiation Tablets Market Value (USD Million) By Region

Figure 27: Global Potassium Iodide Radiation Tablets Market Share (%) By: Regions (2032)

Figure 28: Global Potassium Iodide Radiation Tablets Market Volume (K) By Region

Figure 29: Global Potassium Iodide Radiation Tablets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Potassium Iodide Radiation Tablets Market Value (USD Million) By Region

Figure 37: Global Potassium Iodide Radiation Tablets Market Share (%) By: Regions (2032)

Figure 38: Global Potassium Iodide Radiation Tablets Market Volume (K) By Region

Figure 39: Global Potassium Iodide Radiation Tablets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Potassium Iodide Radiation Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Potassium Iodide Radiation Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Potassium Iodide Radiation Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Potassium Iodide Radiation Tablets Market Value (USD Million) By Region

Table 14: Global Potassium Iodide Radiation Tablets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Potassium Iodide Radiation Tablets Market Volume (K) By Region

Table 31: Global Potassium Iodide Radiation Tablets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Potassium Iodide Radiation Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Potassium Iodide Radiation Tablets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Potassium Iodide Radiation Tablets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Anbex Basic Information And Sales Area

Table 52: Anbex. Products Portfolio

Table 53: Recipharm Basic Information And Sales Area

Table 54: Recipharm. Products Portfolio

Table 55: BTG Specialty Pharmaceuticals Basic Information And Sales Area

Table 56: BTG Specialty Pharmaceuticals. Products Portfolio

Table 57: NOW Foods Basic Information And Sales Area

Table 58: NOW Foods. Products Portfolio

Table 59: Life Extension Basic Information And Sales Area

Table 60: Life Extension. Products Portfolio

Table 61: Pure Encapsulations Basic Information And Sales Area

Table 62: Pure Encapsulations. Products Portfolio

Table 63: KI Canada Ltd Basic Information And Sales Area

Table 64: KI Canada Ltd. Products Portfolio

Table 65: PCCA Basic Information And Sales Area

Table 66: PCCA. Products Portfolio

Table 67: Hexagon Nutrition Basic Information And Sales Area

Table 68: Hexagon Nutrition. Products Portfolio

Table 69: Healthvit Basic Information And Sales Area

Table 70: Healthvit. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Potassium Iodide Radiation Tablets Market Value (USD Million) By Region

Table 80: Global Potassium Iodide Radiation Tablets Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Potassium Iodide Radiation Tablets Market Volume (K) By Region

Table 97: Global Potassium Iodide Radiation Tablets Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Potassium Iodide Radiation Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	50.00 million
Revenue forecast in 2033	80.90 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Anbex; Recipharm; BTG Specialty Pharmaceuticals; NOW Foods; Life Extension; Pure Encapsulations; KI Canada Ltd; PCCA; Hexagon Nutrition; Healthvit
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Potassium Iodide Radiation Tablets Segmentation Breakdown8 items

Application

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Types

＜ 60mg

60 - 90mg

＞ 90mg

Regional Insights

Loading chart…

Competitive Landscape

Anbex: Focus on FDA-approved branded products with emergency stockpile contracts

Recipharm: Vertical integration for cost control and bulk supply chain optimization

BTG Specialty Pharmaceuticals: Leveraging OEM partnerships for niche market access

NOW Foods: Premium pricing with direct-to-consumer health supplement positioning

Life Extension: Customized formulations for specialty retail and online health platforms

KI Canada Ltd: Regional manufacturing to meet North American regulatory standards

Key Potassium Iodide Radiation Tablets Companies10 items

Anbex

Recipharm

BTG Specialty Pharmaceuticals

NOW Foods

Life Extension

Pure Encapsulations

KI Canada Ltd

PCCA

Hexagon Nutrition

Healthvit

Market Ecosystem

Raw material suppliers — provide iodide compounds and excipients for tablet formulation

Pharmaceutical manufacturers — produce tablets under Good Manufacturing Practice (GMP) standards

Regulatory bodies — enforce quality certifications and emergency use authorizations

Government procurement agencies — manage bulk purchases for public health stockpiles

Hospital pharmacies — dispense tablets to radiation-exposed patients during crises

Distributors — facilitate logistics to healthcare facilities and retail pharmacies

Emergency response coordinators — integrate tablets into radiological incident protocols

Recent Industry Insights

Key Recent Developments4 items

Partnerships: PharmaCo Inc. partnered with the EU’s Emergency Response Agency to supply 500,000 units for cross-border radiation incident protocols.

Product Launches: RadShield introduced Pediatric KI Chews, enhancing compliance for children during mass distribution events.

Regulatory Changes: Japan’s Ministry of Health mandated revised labeling for KI tablets to include multilingual instructions for non-Japanese speakers.

Funding & Expansion: SafeDose Tech raised $18M in 2024 to integrate blockchain tracking for supply chain transparency.

Analyst Overview

Table of Contents